Benchmark analyst Bill Sutherland said Omnicell appears to be entering a multi-year period of above-average growth and expanding margins following the recent launch of several products. He expects bookings momentum to continue to build and thinks margin growth could exceed current 2019-2020 consensus, Sutherland added. He raised his price target on Omnicell shares to $79 from $66 and keeps a Buy rating on the stock.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.